在老年人日间医院评估综合临床药剂师模型:一项前性单中心观察性研究
Ine Simal1,2, Andreas Capiau3,4, Anton De Spiegeleer5,6
1Department of Pharmacy, Ghent University Hospital, Ghent, Belgium. ine.simal@uzgent.be.
International journal of clinical pharmacy
|June 4, 2025
概括
临床药剂师 (CP) 在老年患者中有效地发现了与药物相关的问题,并接受了高度的推. 这凸显了老年人日间医院中CP的价值,以优化药物使用和减少不适当的处方.
科学领域:
- 老年医学 老年医学
- 临床药房 临床药房
- 药物经济学 药物经济学
背景情况:
- 药物相关问题 (DRP) 显著影响老年患者的治疗结果.
- 临床药剂师 (CP) 对药物优化至关重要.
- 在日间医院与老年科医生合作的CP的作用需要进一步探索.
研究的目的:
- 为了评估临床药剂师 (CP) 在老年人日间医院的活动.
- 分析已识别的DRP,建议和潜在不合适药物的流行率 (PIM),包括降低风险增加药物 (FRID).
- 评估老年医生对CP建议的接受率和实施率.
主要方法:
- 对25天内参加老年病患日间医院的患者进行了回顾性分析.
- 确定和分类DRP和CP建议.
- 使用了根特老年人处方查工具来识别PIM和FRID.
主要成果:
- 包括99名老年患者 (平均年龄85岁).
- 最常见的DRP是"无征兆",主要涉及神经系统药物.
- 临床医生提出了251条建议 (中位数为2个/患者),接受率为80.1%,立即实施率为73.1%.
- PIM患病率从91.8%降至87.6% (p < .001);FRID中位数保持在2.
结论:
- 临床药剂师 (CP) 是老年医院日间医院跨学科团队的宝贵成员.
- 建议定期重新评估神经系统药物使用情况.
- 应该开始明智的减记,以改善患者的护理.
相关概念视频
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
234
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
234
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
229
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
229
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
238
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
238
Pharmacodynamics in Geriatric Patients: Effects of Age
190
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
190
Drug Dosing: Geriatric Patients
228
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
228
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
198
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
198

